Fig. 5From: Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancerSystemic toxicity assessments. a ALT, b AST, c creatinine, and d BUN values of the mice before and after the treatment. e Repressive images of hematoxylin–eosin staining of heart, liver, spleen, lung, and kidney. In each group, there are 5 miceBack to article page